HU

Hospital Universitario Puerta de Hierro Majadahonda at ISLB 2026

Nov 7–9, 2026 Madrid, Spain ~700 attendees Website

Hospital Universitario Puerta de Hierro Majadahonda brings 3 presentations to ISLB 2026 in Madrid. Its work centres on using circulating tumour DNA (ctDNA) to guide treatment in non-small cell lung cancer. One study, the PALACE phase II trial, tests ctDNA-guided changes to treatment in advanced disease.

OrganizationISLB 2026 Attendance
HU
Hospital Universitario Puerta de Hierro Majadahonda
Majadahonda, Spain
Hospitals & cancer centres
Public university hospital of the Madrid regional health service.
Talk
Sat Nov 7
8:00am–9:30am
Talk
Sun Nov 8
3:00pm–3:45pm
Poster
Part of Poster sessions
Context-dependent Potential of Serial MRD to Guide Chemoimmunotherapy De-escalation in Resectable NSCLC
ctDNA & MRD · Clinical use

Explore the full ISLB 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ISLB 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Hospital Universitario Puerta de Hierro Majadahonda

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the International Society of Liquid Biopsy (ISLB). Submit a correction